Heart Failure With Reduced Ejection Fraction Clinical Trials

44 recruiting

Heart Failure With Reduced Ejection Fraction Trials at a Glance

64 actively recruiting trials for heart failure with reduced ejection fraction are listed on ClinicalTrialsFinder across 6 cities in 30 countries. The largest study group is Not Applicable with 29 trials, with the heaviest enrollment activity in Salt Lake City, Boston, and New York. Lead sponsors running heart failure with reduced ejection fraction studies include Salubris Biotherapeutics Inc, University Medical Center Ho Chi Minh City (UMC), and University of Rochester.

Browse heart failure with reduced ejection fraction trials by phase

Treatments under study

About Heart Failure With Reduced Ejection Fraction Clinical Trials

Looking for clinical trials for Heart Failure With Reduced Ejection Fraction? There are currently 44 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Heart Failure With Reduced Ejection Fraction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Heart Failure With Reduced Ejection Fraction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 64 trials

Recruiting
Not Applicable

Digital Remote Management Versus Usual Care for Optimization of Guideline-directed Medical Therapy in Patients With Heart Failure and Reduced Ejection Fraction: a Multicentre, Randomised, Controlled Trial (DigiCare-HFrEF)

Heart Failure With Reduced Ejection Fraction
Beijing Anzhen Hospital252 enrolled6 locationsNCT07352891
Recruiting

An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting

Chronic Heart Failure With Reduced Ejection Fraction
Bayer1,350 enrolled1 locationNCT06148935
Recruiting
Phase 4

Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score

Heart Failure With Reduced Ejection Fraction
University of Michigan100 enrolled1 locationNCT07490067
Recruiting
Phase 1

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

Heart Failure With Reduced Ejection Fraction
Novartis Pharmaceuticals12 enrolled3 locationsNCT07465653
Recruiting
Not Applicable

Telemedicine-guided Uptitration of Therapy in Chronic Heart Failure

Heart Failure With Reduced Ejection Fraction (HFrEF)
Azienda Unita Sanitaria Locale di Piacenza90 enrolled1 locationNCT07518030
Recruiting
Not Applicable

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

Heart Failure With Reduced Ejection Fraction
VisCardia Inc.270 enrolled1 locationNCT06552637
Recruiting
Not Applicable

Heart Failure Management for Patient With CIED Remotely Monitored

Heart FailureHeart Failure With Reduced Ejection Fraction (HFrEF)Heart Failure NYHA Class III+1 more
Implicity1,132 enrolled1 locationNCT07247032
Recruiting
Not Applicable

Effectiveness of Video Monitoring and Care Transition for Heart Failure Patients (EVIT-HF): Randomized Clinical Trial

Heart Failure With Reduced Ejection Fraction (HFrEF)
Federal University of Uberlandia368 enrolled1 locationNCT06731166
Recruiting

AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices

Cardiovascular DiseasesHeart Failure With Reduced Ejection Fraction (HFrEF)Chronic Heart Failure
University of Salerno205 enrolled1 locationNCT06909682
Recruiting

Prospective Evaluation of AI-ECG for SHD Detection

Heart Failure With Preserved Ejection Fraction (HFpEF; Diagnosis)Valvular Heart Disease Stenosis and Regurgitation (Diagnosis)Pulmonary Hypertension (Diagnosis)+1 more
Imperial College London590 enrolled5 locationsNCT07057466
Recruiting

Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System

Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure NYHA Class IV+1 more
Yale University40,000 enrolled1 locationNCT04237701
Recruiting
Not Applicable

Digital Support Program for Patients With Heart Failure - a Cluster-Randomized Hybrid Type 2 Study

Heart Failure With Reduced Ejection Fraction
Linkoeping University240 enrolled1 locationNCT07275931
Recruiting
Phase 2

Swedish Cardiac And Renal Failure Study-1

Chronic Kidney DiseaseHFrEF - Heart Failure With Reduced Ejection Fraction
Karolinska Institutet40 enrolled1 locationNCT07029503
Recruiting
Phase 2Phase 3

Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy

Heart Failure With Reduced Ejection FractionHeart Rhythm Disorder
Herlev and Gentofte Hospital348 enrolled1 locationNCT06128980
Recruiting
Phase 3

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Heart FailureHeart Failure With Reduced Ejection Fraction
Cytokinetics1,800 enrolled183 locationsNCT06736574
Recruiting
Phase 4

Vericiguat and Reverse Remodeling Indices in Heart Failure

Heart Failure With Reduced Ejection Fraction (HFrEF)Chronic Heart Failure
University Medical Centre Ljubljana60 enrolled1 locationNCT07405944
Recruiting
Early Phase 1

Ketones, SGLT2, HFrEF

Heart Failure With Reduced Ejection FractionType2diabetes
The University of Texas Health Science Center at San Antonio71 enrolled1 locationNCT06229678
Recruiting
Phase 2

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc30 enrolled1 locationNCT07221513
Recruiting

Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure

Pulmonary HypertensionHeart Failure With Reduced Ejection FractionRight Heart Failure Due to Left Heart Failure
Johns Hopkins University50 enrolled1 locationNCT06299436
Recruiting
Not Applicable

Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

Heart Failure With Reduced Ejection Fraction
University of Rochester3,290 enrolled15 locationsNCT06543446